Innovation Pharmaceuticals Inc (IPIX)

[djs7]

Yes, it was well researched. I stopped reading over there when a Stockgumshoe comment was made about Kevetrin that the dosage is so high now at 350 mg/m2 that the patients are swimming in it almost sounding like from the biotech forum's ringleader point of view, there is probably not much extra effect at such high levels. There seemed to be a ringleader impatience from the forum that the K trial should wrapup as dosing at too high levels has little effect. That's when I stopped reading over at that forum. CTIX and DF know whats going on dosage wise and what its worth at this point in time, that's why we continue.